Lightnews — Scholar-powered news

BiotechTV @biotechtv.bsky.social · Jul 31

𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐢𝐨 𝐚𝐭 𝐊𝐞𝐧𝐝𝐚𝐥𝐥 𝐒𝐪𝐮𝐚𝐫𝐞: Do you have unique expertise on a topic in biotech? Are you doing cutting edge research at your company or lab? If so, BiotechTV and @massbio.bsky.social want to help broadcast your story to the world.

1 4

BiotechTV @biotechtv.bsky.social · Jul 31

BiotechTV visited former NIH Director and Co-Founder of ModeX, Elias Zerhouni, yesterday. He has new memoir out covering his extensive career in medicine, academia, government, and industry. It may have some lessons for today’s times.

See the interview: www.biotechtv.com/post/modex-t...

1 2

BiotechTV @biotechtv.bsky.social · Jul 21

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐓𝐨𝐮𝐫: BiotechTV visited the new offices of @seaporttx.bsky.social today and was given a tour by Founder & CEO @daphnezohar.bsky.social

2 3

BiotechTV @biotechtv.bsky.social · Jul 17

𝐀𝐫𝐨𝐮𝐧𝐝 𝐊𝐞𝐧𝐝𝐚𝐥𝐥: Over the weeks and months ahead, BiotechTV is excited to present a new weekly series that will highlight the world capital of biotech, Kendall Square. Please tune in on X, Instagram, and TikTok.

1 3

BiotechTV @biotechtv.bsky.social · Jul 16

𝐎𝐯𝐞𝐫𝐭𝐢𝐦𝐞: Successful biotech entrepreneur Ron Renaud shares his advice for biotech operators today, and gives his take on the state of the industry.

1 1

BiotechTV @biotechtv.bsky.social · Jul 7

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: KalVista’s CEO discusses today's FDA approval and commercial launch of Ekterly, the first oral therapy for treating hereditary angioedema (HAE) attacks.

Full video: www.biotechtv.com/post/kalvist...

1

BiotechTV @biotechtv.bsky.social · Jun 30

𝐐𝐮𝐢𝐜𝐤 𝐓𝐚𝐤𝐞: Today it was announced that AbbVie will be acquiring the in-vivo CAR-T company Capstan Therapeutics for up to $2.1B. Brad Loncar shares his take on what the news could mean for the broader biotech sector.

1 6

BiotechTV @biotechtv.bsky.social · Jun 30

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: Matt Gline speaks with Philip Ross, one of the most experienced and successful bankers in healthcare, about the M&A landscape and his decision to join Jefferies last year.

Full video: www.biotechtv.com/post/off-tar...

1 1

BiotechTV @biotechtv.bsky.social · Jun 29

𝐂𝐀𝐑-𝐓 𝐋𝐨𝐠𝐢𝐜-𝐆𝐚𝐭𝐢𝐧𝐠: ArsenalBio CEO Ken Drazan describes the idea of logic-gating, which might allow CAR-T therapies to work in solid tumors when targeting more than one antigen is needed.

1 3

BiotechTV @biotechtv.bsky.social · Jun 28

𝐑𝐍𝐀 𝐄𝐝𝐢𝐭𝐢𝐧𝐠: Jones Research Senior Healthcare Research Analyst Catherine Novack discusses the latest in the RNA editing space.

Full interview: www.biotechtv.com/post/catheri...

1 2

BiotechTV @biotechtv.bsky.social · Jun 27

𝐒𝐈𝐓𝐂 𝐚𝐭 𝐍𝐘𝐒𝐄: Today we attended the @sitcancer.bsky.social Strategic Meeting at NYSE.

Zhen Su tells us what the meeting is about and why he is excited about IO today.

2 3

BiotechTV @biotechtv.bsky.social · Jun 26

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐓𝐡𝐮𝐫𝐬𝐝𝐚𝐲𝐬: William Blair analyst Andy Hsieh puts odds on Lilly’s pill orforglipron succeeding in obesity after seeing diabetes data at #ADA25 in Chicago.

Hear all of his ADA takeaways here: www.biotechtv.com/post/andy-hs...

1 1

BiotechTV @biotechtv.bsky.social · Jun 26

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Checking in with the co-founders of Amylyx, which now has one program in pivotal, another that may start soon, and earlier stage clinical programs that will have data this year. $AMLX

Full video: www.biotechtv.com/post/amylyx-...

3

BiotechTV @biotechtv.bsky.social · Apr 22

𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐢𝐨 𝐚𝐭 𝐊𝐞𝐧𝐝𝐚𝐥𝐥 𝐒𝐪𝐮𝐚𝐫𝐞: Biotech veteran @artkrieg.bsky.social explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP.

Full video: www.biotechtv.com/post/zola-th...

2

BiotechTV @biotechtv.bsky.social · Apr 14

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: After switching to a new GalNAc-LNP delivery vehicle a year ago, Verve Therapeutics today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor.

Full video: www.biotechtv.com/post/verve-t...

1 3

BiotechTV @biotechtv.bsky.social · Apr 8

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐄𝐎 𝐒𝐢𝐬𝐭𝐞𝐫𝐡𝐨𝐨𝐝: x4 Pharmaceuticals' CEO Paula Ragan on her career and running a commercial stage company in the rare disease space.

Full video: www.biotechtv.com/post/paula-r...

4

BiotechTV @biotechtv.bsky.social · Apr 7

𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐢𝐨 𝐚𝐭 𝐊𝐞𝐧𝐝𝐚𝐥𝐥 𝐒𝐪𝐮𝐚𝐫𝐞: Elias Zerhouni and Andy Plump discuss the future of multispecific biologics. Plus, career advice, biotech compared to pharma, and more.

Full video: www.biotechtv.com/post/elias-z...

5

BiotechTV @biotechtv.bsky.social · Apr 3

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐓𝐡𝐮𝐫𝐬𝐝𝐚𝐲𝐬: Stifel's Alex Thompson updates us on the latest news and upcoming catalysts in the I&I space.

$ARGX $IMVT $ANAB $APGE $DNTH $VRDN

Full video: www.biotechtv.com/post/alex-th...

BiotechTV @biotechtv.bsky.social · Apr 3

𝐀𝐧𝐠𝐥𝐨 𝐍𝐨𝐫𝐝𝐢𝐜 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞: Cure Parkinson's CEO Helen Matthews talks about their work, and participating in the International Linked Clinical Trials Initiative.

Full video: www.biotechtv.com/post/cure-pa...

1

BiotechTV @biotechtv.bsky.social · Apr 3

𝐀𝐧𝐠𝐥𝐨 𝐍𝐨𝐫𝐝𝐢𝐜 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞: Denmark based Synklino is developing a fusion protein that targets US28 for CMV infections from transplants.

Full video: www.biotechtv.com/post/synklin...

BiotechTV @biotechtv.bsky.social · Apr 3

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: On the heels of raising a $65M series B, the CEO of Flagship's Ampersand Biomedicines describes the company's precision medicine platform, and gives updates on partnering and R&D progress.

Full video: www.biotechtv.com/post/ampersa...

5

BiotechTV @biotechtv.bsky.social · Apr 2

𝐁𝐢𝐨𝐓𝐫𝐢𝐧𝐢𝐭𝐲 𝟐𝟎𝟐𝟓: With a novel E3 ubiquitin ligase (TRIM21) for protein degradation, Cambridge, UK based TRIMTECH Therapeutics recently raised a $31 million seed round.

Full video: www.biotechtv.com/post/trimtec...

BiotechTV @biotechtv.bsky.social · Apr 2

𝐁𝐫𝐢𝐠𝐡𝐭 𝐌𝐢𝐧𝐝𝐬: Vida Ventures named Matt Cohen and Brian Goodman new Managing Directors today. BiotechTV caught up with Brian in Vida's Boston office.

Full video: www.biotechtv.com/post/vida-ve...

1

BiotechTV @biotechtv.bsky.social · Apr 2

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: After a $93M series B, Character Bio's CEO Cheng Zhang describes how the company has built a proprietary database to reclassify AMD patients into genetic subgroups to optimize trial patient selection.

Full video: www.biotechtv.com/post/charact...

BiotechTV @biotechtv.bsky.social · Apr 2

𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐢𝐨 𝐚𝐭 𝐊𝐞𝐧𝐝𝐚𝐥𝐥 𝐒𝐪𝐮𝐚𝐫𝐞: Candel Therapeutics CEO Paul Peter Tak and IDEA Pharma CEO Mike Rea on why they believe a different mindset and good communication are keys to succeeding with new innovations in biotech.

Full video: www.biotechtv.com/post/the-stu...